Smith+Nephew debuts dual-mobility system for hip arthroplasty: 3 things to know

Written by Angie Stewart | November 08, 2019 | Print  |

Smith+Nephew launched its OR3O Dual Mobility System on Nov. 8 for use in primary and revision hip arthroplasty. 

Three things to know:

1. The system's dual-mobility implants have a smaller diameter femoral head than traditional solutions. The head locks into a larger polyethylene insert to increase stability and improve range of motion.

2. OR3O features Smith+Nephew's Oxinium Diffusion Hardened metal alloy and Verilast technology. It is designed to cause less wear than competing products that use cobalt-chrome.

3. Smith+Nephew's OR3O Dual Mobility System is available in the United States for both primary and revision applications. It offers cross-compatibility with the R3 and REDAPT acetabular systems.

More articles on surface technology:
Orthofix reports $40.5M loss & more: 7 device company notes
SeaSpine posts $39.9M Q3 revenue
Stryker receives FDA clearance for 3D-printed expandable interbody device — 4 things to know 

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers